.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Federal Trade Commission
Teva
AstraZeneca
Colorcon
Covington
Baxter
Mallinckrodt
Queensland Health
Merck

Generated: July 27, 2017

DrugPatentWatch Database Preview

JENLOGA Drug Profile

« Back to Dashboard

Which patents cover Jenloga, and when can generic versions of Jenloga launch?

Jenloga is a drug marketed by Concordia Pharms Inc and is included in one NDA.

The generic ingredient in JENLOGA is clonidine hydrochloride. There are twenty-one drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. Additional details are available on the clonidine hydrochloride profile page.

Summary for Tradename: JENLOGA

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list70
Patent Applications: see list1,299
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:JENLOGA at DailyMed

Pharmacology for Tradename: JENLOGA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Concordia Pharms Inc
JENLOGA
clonidine hydrochloride
TABLET, EXTENDED RELEASE;ORAL022331-001Sep 30, 2009DISCNYesNo► Subscribe► Subscribe► Subscribe
Concordia Pharms Inc
JENLOGA
clonidine hydrochloride
TABLET, EXTENDED RELEASE;ORAL022331-002May 25, 2010DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: JENLOGA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Concordia Pharms Inc
JENLOGA
clonidine hydrochloride
TABLET, EXTENDED RELEASE;ORAL022331-001Sep 30, 2009► Subscribe► Subscribe
Concordia Pharms Inc
JENLOGA
clonidine hydrochloride
TABLET, EXTENDED RELEASE;ORAL022331-002May 25, 2010► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: JENLOGA

Drugname Dosage Strength RLD Submissiondate
clonidine hydrochlorideExtended-release Tablets0.1 mg and 0.2 mgJenloga3/4/2011
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Boehringer Ingelheim
Accenture
Healthtrust
Johnson and Johnson
Covington
Novartis
Chinese Patent Office
Merck
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot